novo nordisk weight loss - Search News

Novo Nordisk’s stock is rallying

Wall Street Journal · 2h

Novo Nordisk Stock Rises on Weight-Loss Retreat by Hims & Hers

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood about 17% lower at under $42.

Hosted on MSN · 53m

Novo Nordisk A/S (NVO): Jim Cramer’s Take on Weight Loss Drug Giant’s Future

We recently published a list of Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against Health Insurance Companies. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks that Jim Cramer Discusses with insights on Trump DOJ’s action against health insurance companies.

MarketWatch on MSN · 4h

Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.

Novo Nordisk, Food and Drug Administration and Ozempic

USA TODAY on MSN · 2d

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.

NBC New York · 4d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Reuters on MSN · 18h

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list,

2h

Lilly offers weight-loss drugs in vials at a discount to fight competition

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...

22h

Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

14hon MSN

Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended ...

17h

Hims & Hers warns it may stop selling compounded weight-loss drugs

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

FoodNavigator23h

Is this GLP-1.2? New generation of weight-loss drugs moving in

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

2hon MSN

Novo Nordisk A/S (NVO): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years

We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...

4d

Weight-loss drugs are about to get a lot better

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

6d

Are Weight Loss Injections Safe? What to Know Before Starting One

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results